157 related articles for article (PubMed ID: 18784736)
21. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.
Munkhaugen J; Lydersen S; Widerøe TE; Hallan S
Am J Kidney Dis; 2009 Oct; 54(4):638-46. PubMed ID: 19515474
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
[TBL] [Abstract][Full Text] [Related]
23. Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study.
Kronborg J; Solbu M; Njølstad I; Toft I; Eriksen BO; Jenssen T
Nephrol Dial Transplant; 2008 Sep; 23(9):2818-26. PubMed ID: 18400822
[TBL] [Abstract][Full Text] [Related]
24. Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
Whaley-Connell A; Sowers JR; McCullough PA; Roberts T; McFarlane SI; Chen SC; Li S; Wang C; Collins AJ; Bakris GL;
Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S11-21. PubMed ID: 19285607
[TBL] [Abstract][Full Text] [Related]
25. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study.
Ninomiya T; Kiyohara Y; Kubo M; Yonemoto K; Tanizaki Y; Doi Y; Hirakata H; Iida M
Am J Kidney Dis; 2006 Sep; 48(3):383-91. PubMed ID: 16931211
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and treatment of cardiovascular disease and traditional risk factors in Australian adults with renal insufficiency.
Briganti EM; Kerr PG; Shaw JE; Zimmet PZ; Atkins RC
Nephrology (Carlton); 2005 Feb; 10(1):40-7. PubMed ID: 15705181
[TBL] [Abstract][Full Text] [Related]
27. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults.
Tozawa M; Iseki C; Tokashiki K; Chinen S; Kohagura K; Kinjo K; Takishita S; Iseki K
Hypertens Res; 2007 Oct; 30(10):937-43. PubMed ID: 18049025
[TBL] [Abstract][Full Text] [Related]
28. High prevalence of gout in patients with Type 2 diabetes: male sex, renal impairment, and diuretic use are major risk factors.
Suppiah R; Dissanayake A; Dalbeth N
N Z Med J; 2008 Oct; 121(1283):43-50. PubMed ID: 18841184
[TBL] [Abstract][Full Text] [Related]
29. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study.
Noda H; Iso H; Saito I; Konishi M; Inoue M; Tsugane S;
Hypertens Res; 2009 Apr; 32(4):289-98. PubMed ID: 19262490
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15).
Yokoyama H; Sone H; Oishi M; Kawai K; Fukumoto Y; Kobayashi M;
Nephrol Dial Transplant; 2009 Apr; 24(4):1212-9. PubMed ID: 18984626
[TBL] [Abstract][Full Text] [Related]
31. [Predictors of chronic kidney disease in hypertensive patients].
Grabysa R; Cholewa M
Pol Merkur Lekarski; 2008 Jul; 25(145):9-14. PubMed ID: 18839606
[TBL] [Abstract][Full Text] [Related]
32. Glomerular hyperfiltration and metabolic syndrome: results from the FIrenze-BAgno A Ripoli (FIBAR) Study.
Monami M; Pala L; Bardini G; Francesconi P; Cresci B; Marchionni N; Rotella CM; Mannucci E
Acta Diabetol; 2009 Sep; 46(3):191-6. PubMed ID: 18989613
[TBL] [Abstract][Full Text] [Related]
33. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
[TBL] [Abstract][Full Text] [Related]
34. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey.
Kjeldsen SE; Naditch-Brule L; Perlini S; Zidek W; Farsang C
J Hypertens; 2008 Oct; 26(10):2064-70. PubMed ID: 18806632
[TBL] [Abstract][Full Text] [Related]
35. Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study.
Ilanne-Parikka P; Eriksson JG; Lindström J; Peltonen M; Aunola S; Hämäläinen H; Keinänen-Kiukaanniemi S; Laakso M; Valle TT; Lahtela J; Uusitupa M; Tuomilehto J;
Diabetes Care; 2008 Apr; 31(4):805-7. PubMed ID: 18184907
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of metabolic syndrome among middle aged women in Babol, Iran.
Delavar MA; Lye MS; Khor GL; Hanachi P; Hassan ST
Southeast Asian J Trop Med Public Health; 2009 May; 40(3):612-28. PubMed ID: 19842450
[TBL] [Abstract][Full Text] [Related]
37. An association between body mass index and estimated glomerular filtration rate.
Kawamoto R; Kohara K; Tabara Y; Miki T; Ohtsuka N; Kusunoki T; Yorimitsu N
Hypertens Res; 2008 Aug; 31(8):1559-64. PubMed ID: 18971530
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus infection and the prevalence of renal insufficiency.
Dalrymple LS; Koepsell T; Sampson J; Louie T; Dominitz JA; Young B; Kestenbaum B
Clin J Am Soc Nephrol; 2007 Jul; 2(4):715-21. PubMed ID: 17699487
[TBL] [Abstract][Full Text] [Related]
39. The metabolic syndrome: similar deleterious impact on all-cause mortality in hypertensive and normotensive subjects.
Pannier B; Thomas F; Bean K; Jégo B; Benetos A; Guize L
J Hypertens; 2008 Jun; 26(6):1223-8. PubMed ID: 18475161
[TBL] [Abstract][Full Text] [Related]
40. The impact of the metabolic syndrome on the patients with acute coronary syndrome.
Agoşton-Coldea L; Mocan T; Rusu LD; Pais R; Albu A; Rusu ML; Perna S
Rom J Intern Med; 2008; 46(1):55-62. PubMed ID: 19157271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
